TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.

Blohmke, C; Park, J; Hirschfeld, A; Victor, R; Schneiderman, J; Stefanowicz, D; Chilvers, M; Durie, P; Corey, M; Zielenski, J; Dorfman, R; Sandford, A; Daley, D; Turvey, SE

Journal article

TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.

Abstract:: New treatments are needed to improve the health of people with cystic fibrosis (CF). Reducing lung-damaging inflammation is likely to be beneficial, but specific anti-inflammatory targets have not been identified. By combining cellular immunology with a population-based genetic modifier study, we examined TLR5 as an anti-inflammatory target and modifier gene in CF. Using two pairs of human CF and control airway epithelial cells, we demonstrated that the TLR5-flagellin interaction is a major mediator of inflammation following exposure to Pseudomonas aeruginosa. To validate TLR5 as an anti-inflammatory target, we analyzed the disease modifying effects of the TLR5 c.1174C>T single nucleotide polymorphism (rs5744168) in a large cohort of CF patients (n = 2219). rs5744168 encodes a premature stop codon and the T allele is associated with a 45.5-76.3% reduction in flagellin responsiveness (p < 0.0001). To test the hypothesis that reduced TLR5 responsiveness would be associated with improved health in CF patients, we examined the relationship between rs5744168 and two clinical phenotypes: lung function and body weight. Adults with CF carrying the TLR5 premature stop codon (CT or TT genotype) had a higher body mass index than did CF patients homozygous for the fully functional allele (CC genotype) (p = 0.044); however, similar improvements in lung function associated with the T allele were not statistically significant. Although follow-up studies are needed to confirm the impact of TLR5 on nutritional status, this translational research provides evidence that genetic variation in TLR5 resulting in reduced flagellin responsiveness is associated with improved health indicators in adults with CF.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Blohmke, C., Park, J., Hirschfeld, A., Victor, R., Schneiderman, J., Stefanowicz, D., Chilvers, M., Durie, P., Corey, M., Zielenski, J., Dorfman, R., Sandford, A., Daley, D., & Turvey, S. E. (2010). TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis. Journal of Immunology, 185(12), 7731–7738.

MLA Style

Blohmke, C., et al. “TLR5 As an Anti-Inflammatory Target and Modifier Gene in Cystic Fibrosis.” Journal of Immunology, vol. 185, no. 12, 2010, pp. 7731–38.

Chicago Style

Blohmke, C, J Park, A Hirschfeld, R Victor, J Schneiderman, D Stefanowicz, M Chilvers, et al. 2010. “TLR5 As an Anti-Inflammatory Target and Modifier Gene in Cystic Fibrosis.” Journal of Immunology 185 (12): 7731–38.
Share
Print